162 related articles for article (PubMed ID: 31901365)
1. Thick melanomas without lymph node metastases: A forgotten group with poor prognosis.
El Sharouni MA; Witkamp AJ; Sigurdsson V; van Diest PJ; Suijkerbuijk KPM
Eur J Surg Oncol; 2020 May; 46(5):918-923. PubMed ID: 31901365
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis?
Han D; Han G; Morrison S; Leong SP; Kashani-Sabet M; Vetto J; White R; Schneebaum S; Pockaj B; Mozzillo N; Sondak VK; Zager JS
Surgery; 2020 Sep; 168(3):518-526. PubMed ID: 32669204
[TBL] [Abstract][Full Text] [Related]
3. Excision margins and sentinel lymph node status as prognostic factors in thick melanoma of the head and neck: A retrospective analysis.
Ruskin O; Sanelli A; Herschtal A; Webb A; Dixon B; Pohl M; Donahoe S; Spillane J; Henderson MA; Gyorki DE
Head Neck; 2016 Sep; 38(9):1373-9. PubMed ID: 27014970
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
[TBL] [Abstract][Full Text] [Related]
5. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?
Fadaki N; Li R; Parrett B; Sanders G; Thummala S; Martineau L; Cardona-Huerta S; Miranda S; Cheng ST; Miller JR; Singer M; Cleaver JE; Kashani-Sabet M; Leong SP
Ann Surg Oncol; 2013 Sep; 20(9):3089-97. PubMed ID: 23649930
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomas.
White I; Fortino J; Curti B; Vetto J
Am J Surg; 2014 May; 207(5):702-7; discussion 707. PubMed ID: 24791630
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
8. Prognosis and Management of Thick and Ultrathick Melanoma.
Blakely AM; Cohen JT; Comissiong DS; Vezeridis MP; Miner TJ
Am J Clin Oncol; 2019 Nov; 42(11):824-829. PubMed ID: 31517636
[TBL] [Abstract][Full Text] [Related]
9. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients.
Fujisawa Y; Otsuka F;
Melanoma Res; 2012 Oct; 22(5):362-7. PubMed ID: 22713797
[TBL] [Abstract][Full Text] [Related]
10. Patterns of failure in patients with cutaneous head and neck melanoma.
Bachar G; Tzelnick S; Amiti N; Gutman H
Eur J Surg Oncol; 2020 May; 46(5):914-917. PubMed ID: 31952929
[TBL] [Abstract][Full Text] [Related]
11. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
Gambichler T; Scholl L; Bechara FG; Stockfleth E; Stücker M
Eur J Surg Oncol; 2016 Sep; 42(9):1420-6. PubMed ID: 27160354
[TBL] [Abstract][Full Text] [Related]
12. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
13. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma.
Boada A; Tejera-Vaquerizo A; Ribero S; Puig S; Moreno-Ramírez D; Quaglino P; Osella-Abate S; Cassoni P; Malvehy J; Carrera C; Pigem R; Barreiro-Capurro A; Requena C; Traves V; Manrique-Silva E; Fernández-Orland A; Ferrandiz L; García-Senosiain O; Fernández-Figueras MT; Ferrándiz C; Nagore E;
Eur J Surg Oncol; 2020 Feb; 46(2):263-271. PubMed ID: 31594672
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
Yamamoto M; Fisher KJ; Wong JY; Koscso JM; Konstantinovic MA; Govsyeyev N; Messina JL; Sarnaik AA; Cruse CW; Gonzalez RJ; Sondak VK; Zager JS
Cancer; 2015 May; 121(10):1628-36. PubMed ID: 25677366
[TBL] [Abstract][Full Text] [Related]
16. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
Wong SL; Faries MB; Kennedy EB; Agarwala SS; Akhurst TJ; Ariyan C; Balch CM; Berman BS; Cochran A; Delman KA; Gorman M; Kirkwood JM; Moncrieff MD; Zager JS; Lyman GH
Ann Surg Oncol; 2018 Feb; 25(2):356-377. PubMed ID: 29236202
[TBL] [Abstract][Full Text] [Related]
17. Primary dermal melanoma: clinical behaviour, prognosis and treatment.
Harris CG; Lo S; Ahmed T; Scolyer RA; Ferguson PM; Karim RZ; Lam TK; Lee KK; Shannon KF; Spillane AJ; Stretch JR; Thompson JF; Saw RP
Eur J Surg Oncol; 2020 Nov; 46(11):2131-2139. PubMed ID: 32417156
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node mapping for thick (>or=4-mm) melanoma: should we be doing it?
Carlson GW; Murray DR; Hestley A; Staley CA; Lyles RH; Cohen C
Ann Surg Oncol; 2003 May; 10(4):408-15. PubMed ID: 12734090
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas.
Gutzmer R; Satzger I; Thoms KM; Völker B; Mitteldorf C; Kapp A; Bertsch HP; Kretschmer L
J Dtsch Dermatol Ges; 2008 Mar; 6(3):198-203. PubMed ID: 18093216
[TBL] [Abstract][Full Text] [Related]
20. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR
Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
